Advertisement
Correspondence| Volume 86, P134, May 2021

Download started.

Ok

Response to “Comment on: “Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information”

      We appreciate and agree with Artusi and Espay about the potential of wearable technologies for capturing a wide variety of disease manifestations in patients with Parkinson's disease (PD), including novel (e.g., non-motor) features that can also be related to disability and quality of life. The type and nature of these features and devices required to measure them remain yet to be determined and form an important area of present and future work [
      • Merola A.
      • Sturchio A.
      • Hacker S.
      • Serna S.
      • Vizcarra J.A.
      • Marsili L.
      • Fasano A.
      • Espay A.J.
      Technology-based assessment of motor and nonmotor phenomena in Parkinson disease.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Merola A.
        • Sturchio A.
        • Hacker S.
        • Serna S.
        • Vizcarra J.A.
        • Marsili L.
        • Fasano A.
        • Espay A.J.
        Technology-based assessment of motor and nonmotor phenomena in Parkinson disease.
        Expert Rev. Neurother. 2018 Nov; 18 (Epub 2018 Oct 8. PMID: 30269610): 825-845https://doi.org/10.1080/14737175.2018.1530593
        • Ghoraani B.
        • Galvin J.E.
        • Jimenez-Shahed J.
        Point of view: wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information.
        Park. Relat. Disord. 2021 Mar; 84 (Epub 2021 Jan 30. PMID: 33549914): 35-39https://doi.org/10.1016/j.parkreldis.2021.01.022
        • Artusi C.A.
        • Mishra M.
        • Latimer P.
        • Vizcarra J.A.
        • Lopiano L.
        • Maetzler W.
        • Merola A.
        • Espay A.J.
        Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases.
        Park. Relat. Disord. 2018 Jan; 46 (Suppl 1(Suppl 1)) (Epub 2017 Jul 26. PMID: 28760593; PMCID: PMC7924909): S53-S56https://doi.org/10.1016/j.parkreldis.2017.07.022
        • Stacy M.A.
        • Murck H.
        • Kroenke K.
        Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.
        Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2010 Feb 1; 34 (Epub 2009 Sep 28. PMID: 19793544): 57-61https://doi.org/10.1016/j.pnpbp.2009.09.023
        • Kleiner G.
        • Fernandez H.H.
        • Chou K.L.
        • Fasano A.
        • Duque K.R.
        • Hengartner D.
        • Law A.
        • Margolius A.
        • Poon Y.Y.
        • Sáenz Farret M.
        • Saleh P.
        • Vizcarra J.A.
        • Stebbins G.T.
        • Espay A.J.
        • PSG NoMoFA Study Group
        Non-motor fluctuations in Parkinson's disease: validation of the non-motor fluctuation assessment questionnaire.
        Mov. Disord. 2021 Feb 15; (Epub ahead of print. PMID: 33590555)https://doi.org/10.1002/mds.28507